ArticleTranslational oncology2013

High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer.

Daniel C Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.